Voyant Open Fusion Device Models: EB040 and EB040+ Product Usage: The Applied Voyant Open Fu...

FDA Device Recall #Z-2769-2015 — Class II — July 31, 2015

Recall Summary

Recall Number Z-2769-2015
Classification Class II — Moderate risk
Date Initiated July 31, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Applied Medical Resources Corp
Location Rancho Santa Margarita, CA
Product Type Devices
Quantity 101 units (U.S) and 38 units (International)

Product Description

Voyant Open Fusion Device Models: EB040 and EB040+ Product Usage: The Applied Voyant Open Fusion Device is designed for use with the Voyant Electrosurgical Generator. The device is an advanced bipolar instrument that uses RF energy, provided by the generator, to seal vessels up to and including 5mm (EB040+) or 7mm (EB040) in diameter. The device may also be used to seal tissue bundles that can be captured in the device jaws. The system delivers the energy required to fuse the tissue between the jaws of the device by monitoring voltage and current throughout the seal cycle. The device also features a useractuated blade for the transection of sealed tissue.

Reason for Recall

Potential to improperly characterize tissue within the jaws, which may result in nonoptimal power delivery.

Distribution Pattern

Worldwide Distribution - U.S Nationwide in the states of:FL, GA, NV. and countries of: France, Netherlands, Spain, and United Kingdom.

Lot / Code Information

Model Number: EB040 Lot Numbers: 1243964, 1243975, 1244125 Model Number: EB040+ Lot Numbers: 1245512, 1245513, 1246241, 1246508, 1247079, 1247566, 1248102, 1249264

Other Recalls from Applied Medical Resources Corp

Recall # Classification Product Date
Z-1010-2026 Class II Kii Low Profile, Bladed Dual Pack , Qty. 1 5x55... Dec 11, 2025
Z-1388-2024 Class II Epix Universal Clip Applier, REF: CA500, STERILEEO Jan 30, 2024
Z-1389-2024 Class II Epix Universal Clip Applier, REF: CA500, STERIL... Jan 30, 2024
Z-2160-2020 Class II DR. THAMES - LAP CHOLE, REF: K0880, UDI: (01)3... Mar 17, 2020
Z-2161-2020 Class II Clip Applier Kit, REF: K2887, UDI: (01)30607915... Mar 17, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.